Nab-paclitaxel combined with oxaliplatin and S-1 as conversion therapy for advanced gastric adenocarcinoma.

被引：0
|
作者：
Ji, Ke
Bu, Zhaode
Yang, Heli
Wang, Zhenning
Liu, Funan
Liang, Pin
Dong, Yan
Zhang, Jie
Zhao, Qun
Liu, Yang
Ji, Jiafu
机构：
[1] Beijing Canc Hosp, Beijing, Peoples R China
[2] Peking Univ Canc Hosp, Minist Educ, Dept Gastrointestinal Surg, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China
[3] China Med Univ, Affiliated Hosp 1, Shenyang, Peoples R China
[4] First Hosp China Med Univ, Shenyang, Peoples R China
[5] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China
[6] Fourth Hosp Hebei Med Univ, Shijiazhuang, Peoples R China
[7] Fourth Hosp Hebei Med Univ, Hebei Tumor Hosp, Shijiazhuang, Hebei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
343
引用
收藏
页码：343 / 343
页数：1
相关论文
共 50 条
  • [21] Phase I/II study of nab-paclitaxel combined with S-1 as adjuvant chemotherapy in diffuse type of stage III gastric or gastroesophageal junction adenocarcinoma
    Cui, Yuehong
    Wei, Jia
    Yu, Yiyi
    Xu, Bei
    Wu, Jing
    Xu, Xiaojing
    Liu, Tianshu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
    Dai, Yu-Hong
    Yu, Xiong-Jie
    Xu, Hui-Ting
    Zhuang, Liang
    Zhang, Ming-Sheng
    Zou, Yan-Mei
    Fu, Qiang
    Qiu, Hong
    Yuan, Xiang-Lin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [23] Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study
    Jin, Min
    Liu, Hong-Li
    Xue, Jun
    Ma, Hong
    Liu, Jun-Li
    Lin, Zhen-Yu
    Wang, Jing
    Bao, Le-Qun
    Luo, Zhi-Guo
    Yu, Xiong-Jie
    Li, Shuang
    Hu, Jian-Li
    Zhang, Tao
    ONCOLOGIST, 2024, 29 (10): : e1406 - e1418
  • [24] Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Oxaliplatin as Induction Therapy for Patients with Advanced Gastric Cancer with Peritoneal Metastases
    Saito, Shin
    Yamaguchi, Hironori
    Ohzawa, Hideyuki
    Miyato, Hideyo
    Kanamaru, Rihito
    Kurashina, Kentaro
    Hosoya, Yoshinori
    Lefor, Alan Kawarai
    Sata, Naohiro
    Kitayama, Joji
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (07) : 3863 - 3870
  • [25] Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Oxaliplatin as Induction Therapy for Patients with Advanced Gastric Cancer with Peritoneal Metastases
    Shin Saito
    Hironori Yamaguchi
    Hideyuki Ohzawa
    Hideyo Miyato
    Rihito Kanamaru
    Kentaro Kurashina
    Yoshinori Hosoya
    Alan Kawarai Lefor
    Naohiro Sata
    Joji Kitayama
    Annals of Surgical Oncology, 2021, 28 : 3863 - 3870
  • [26] Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer
    Kawamoto, Yasuyuki
    Komatsu, Yoshito
    Yuki, Satoshi
    Sawada, Kentaro
    Muranaka, Tetsuhito
    Harada, Kazuaki
    Nakatsumi, Hiroshi
    Fukushima, Hiraku
    Ishiguro, Atsushi
    Dazai, Masayoshi
    Hatanaka, Kazuteru
    Nakamura, Michio
    Iwanaga, Ichiro
    Uebayashi, Minoru
    Sogabe, Susumu
    Kobayashi, Yoshimitsu
    Miyagishima, Takuto
    Ono, Kota
    Sakamoto, Naoya
    Sakata, Yuh
    BMC CANCER, 2017, 17
  • [27] A Phase I Study of Gemcitabine/Nab-Paclitaxel/S-1 Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
    Chang, Chen
    Li, Xiaofen
    Cheng, Ke
    Cai, Zhaolun
    Xiong, Junjie
    Lv, Wanrui
    Li, Ruizhen
    Zhang, Pei
    Cao, Dan
    ONCOLOGIST, 2023, 28 (07): : E575 - E584
  • [28] Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer
    Yasuyuki Kawamoto
    Yoshito Komatsu
    Satoshi Yuki
    Kentaro Sawada
    Tetsuhito Muranaka
    Kazuaki Harada
    Hiroshi Nakatsumi
    Hiraku Fukushima
    Atsushi Ishiguro
    Masayoshi Dazai
    Kazuteru Hatanaka
    Michio Nakamura
    Ichiro Iwanaga
    Minoru Uebayashi
    Susumu Sogabe
    Yoshimitsu Kobayashi
    Takuto Miyagishima
    Kota Ono
    Naoya Sakamoto
    Yuh Sakata
    BMC Cancer, 17
  • [29] A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma
    Naru Kondo
    Yoshiaki Murakami
    Kenichiro Uemura
    Takeshi Sudo
    Yasushi Hashimoto
    Naoya Nakagawa
    Shinya Takahashi
    Hiroki Ohge
    Taijiro Sueda
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 775 - 781
  • [30] Nab-paclitaxel plus S-1 in advanced pancreatic adenocarcinoma (NPSPAC): a single arm, single center, phase II trial
    Shi, Yan
    Zhang, Sui
    Han, Quanli
    Li, Jie
    Yan, Huan
    Lv, Yao
    Shi, Huaiyin
    Liu, Rong
    Dai, Guanghai
    ONCOTARGET, 2017, 8 (54) : 92401 - 92410
12345